Actively Recruiting

Age: 18Years - 89Years
All Genders
Healthy Volunteers
ID07502989

Convenient Quantification of Myopathic Change in Muscle Via Electrical Impedance Myography

Led by Beth Israel Deaconess Medical Center · Updated on 2026-04-03

150

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

Sponsors

B

Beth Israel Deaconess Medical Center

Lead Sponsor

N

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating a device called the mScan, which uses Electrical Impedance Myography (EIM) to measure muscle health in people with and without muscle diseases. The study aims to compare the mScan's measurements with those from magnetic resonance imaging (MRI), which is commonly used to track muscle conditions but has limitations like high cost and inconvenience. The goal is to develop a quicker, easier, and less expensive way to assess muscle health that could help monitor treatment effects in muscle disorders. The study involves using the mScan device, which applies a small, painless electrical current to muscles and records the muscle's response. This technology is being studied as a potential alternative to MRI because it is faster, more convenient, and does not require complex image analysis. Participants include healthy individuals and those with muscle diseases called myopathies. The study compares muscle measurements from the mScan with those from MRI over two years. Participants will undergo assessments using both the mScan device and MRI scans to collect data on muscle condition, including muscle size, fat content, swelling, and fiber organization. Researchers will apply machine learning to connect the mScan data with MRI findings to create predictive models of muscle pathology. The study may also involve DXA scans and excludes those with certain conditions that interfere with these tests. The total study duration is two years, focusing on developing algorithms to improve muscle disease assessment.

CONDITIONS

Brief Title

Muscle Health Measurements Using Electrical Impedance Myography

Who Can Participate

Age: 18Years - 89Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 18 to 89 years
  • Evidence of a primary myopathic condition confirmed by chart review, genetic testing, serology, or prior muscle biopsy
Not Eligible

You will not qualify if you...

  • Inability to lie flat or history of claustrophobia
  • More than mild lower extremity swelling
  • Multiple other conditions affecting lower leg muscles
  • Pregnancy
  • MRI contraindications such as incompatible pacemaker, deep brain stimulator, or hardware
  • Contraindications to DXA scan including recent radioisotope or contrast imaging, weight over 450 lbs, recent calcium supplements
  • Severe obesity with BMI over 35
  • Chronic skin conditions causing ulcers that interfere with the device electrodes or cause discomfort

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 2 years

Participants undergo Electrical Impedance Myography (EIM) measurements to assess muscle health as a proxy for MRI.

Visits scheduled as needed during the study period

Long-term Monitoring

Duration - Up to 2 years

Participants are monitored over time to track changes in muscle pathology using EIM data.

Periodic visits for assessments during the study period

Trial Site Locations

Total: 1 location

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Phase 1 Dose Evaluation Study of the Safety and Preliminar...

SLE (Systemic Lupus)

Actively Recruiting

8 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Simultaneous muscle water T2 and fat fraction mapping using transverse relaxometry with stimulated echo compensation.

Benjamin Marty, Pierre-Yves Baudin, Harmen Reyngoudt...

https://pubmed.ncbi.nlm.nih.gov/26814454

Cross-sectional evaluation of electrical impedance myography and quantitative ultrasound for the assessment of Duchenne muscular dystrophy in a clinical trial setting.

Seward B Rutkove, Tom R Geisbush, Aleksandar Mijailovic...

https://pubmed.ncbi.nlm.nih.gov/24814059

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.

Craig M McDonald, Erik K Henricson, R Ted Abresch...

https://pubmed.ncbi.nlm.nih.gov/23674289

Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies [RETIRED]: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Pushpa Narayanaswami, Michael Weiss, Duygu Selcen...

https://pubmed.ncbi.nlm.nih.gov/25313375

Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration.

Nathalie Goemans, Brenda Wong, Marleen Van den Hauwe...

https://pubmed.ncbi.nlm.nih.gov/32555695

Estimating myofiber cross-sectional area and connective tissue deposition with electrical impedance myography: A study in D2-mdx mice.

Sarbesh R Pandeya, Janice A Nagy, Daniela Riveros...

https://pubmed.ncbi.nlm.nih.gov/33759456

Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that may serve as a convenient index of disease status.

Seward B Rutkove, Jim S Wu, Craig Zaidman...

https://pubmed.ncbi.nlm.nih.gov/27825055